Human adrenomedullin and its binding protein attenuate organ injury and reduce mortality after hepatic ischemia-reperfusion

Annals of Surgery

Volumn 249, Issue 2, 2009, Pages 310-317

  Yang, Juntao ^a   Wu, Rongqian ^a,b   Qiang, Xiaoling ^a,b   Zhou, Mian ^a,b   Dong, Weifeng ^a   Ji, Youxin ^a   Marini, Corrado P ^a   Ravikumar, Thanjavur S ^a,b   Wang, Ping ^a,b  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; ADRENOMEDULLIN BINDING PROTEIN 1; BINDING PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ADM PROTEIN, HUMAN; ADRENOMEDULLIN BINDING PROTEIN 1, HUMAN; ADRENOMEDULLIN-BINDING PROTEIN 1, HUMAN; COMPLEMENT FACTOR H; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MECHANISM; HYPOXEMIA; LIVER ISCHEMIA; MALE; MORTALITY; NONHUMAN; ORGAN INJURY; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; TISSUE INJURY; ANIMAL; DISEASE MODEL; LIVER; LIVER DISEASE; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ADRENOMEDULLIN; ANIMALS; COMPLEMENT FACTOR H; DISEASE MODELS, ANIMAL; LIVER; LIVER DISEASES; MALE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; VASODILATOR AGENTS;

EID: 61549137462     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181961d43     Document Type: Article

References (55)

1. Banga NR, Homer-Vanniasinkam S, Graham A, et al. Ischaemic preconditioning in transplantation and major resection of the liver. Br J Surg. 2005;92:528-538.
2. Koti RS, Seifalian AM, Davidson BR. Protection of the liver by ischemic preconditioning: a review of mechanisms and clinical applications. Dig Surg. 2003;20:383-396.
3. Kharbanda RK, Mortensen UM, White PA, et al. Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation. 2002;106: 2881-2883.
4. Fondevila C, Busuttil RW, Kupiec-Weglinski JW. Hepatic ischemia/reperfu-sion injury-a fresh look. Exp Mol Pathol. 2003;74:86-93.
5. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol. 2003;284: G15-G26.
6. Kitamura K, Kangawa K, Kawamoto M, et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun. 1993;192:553-560.
7. Hinson JP, Kapas S, Smith DM. Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev. 2000;21:138-167.
8. Elsasser TH, Kahl S, Martinez A, et al. Adrenomedullin binding protein in the plasma of multiple species: characterization by radioligand blotting. Endocrinol. 1999;140:4908-4911.
9. Pio R, Martinez A, Unsworth EJ, et al. Complement factor H is a serum binding protein for adrenomedullin. The resulting complex modulates the bioactivities of both partners. J Biol Chem. 2001;276:12292-12300.
10. Yang S, Zhou M, Chaudry IH, et al. Novel approach to prevent the transition from the hyperdynamic phase to the hypodynamic phase of sepsis: role of adrenomedullin and adrenomedullin binding protein-1. Ann Surg. 2002;236: 625-633.
11. Zhou M, Simms HH, Wang P. Adrenomedullin and adrenomedullin binding protein-1 attenuate vascular endothelial cell apoptosis in sepsis. Ann Surg. 2004;240:321-330.
12. Carrizo GJ, Wu R, Cui X, et al. Adrenomedullin and adrenomedullin-binding protein-1 downregulate inflammatory cytokines and attenuate tissue injury after gut ischemia-reperfusion. Surgery. 2007;141:245-253.
13. Wu R, Cui X, Dong W, et al. Mechanisms responsible for vascular hyporesponsiveness to adrenomedullin after hemorrhage: the central role of adrenomedullin binding protein-1. Ann Surg. 2005;242:115-123.
14. Dwivedi AJ, Wu R, Nguyen E, et al. Adrenomedullin and adrenomedullin binding protein-1 prevent acute lung injury after gut ischemia-reperfusion. J Am Coll Surg. 2007;205:284-293.
15. Heijnen BH, Straatsburg IH, Gouma DJ, et al. Decrease in core liver temperature with 10 degrees C by in situ hypothermic perfusion under total hepatic vascular exclusion reduces liver ischemia and reperfusion injury during partial hepatectomy in pigs. Surgery. 2003;134:806-817.
16. Schauer RJ, Gerbes AL, Vonier D, et al. Glutathione protects the rat liver against reperfusion injury after prolonged warm ischemia. Ann Surg. 2004; 239:220-231.
17. Wang D, Dou K, Song Z, et al. The Na+/H+ exchange inhibitor: a new therapeutic approach for hepatic ischemia injury in rats. Transplant Proc. 2003;35:3134-3135.
18. Hayakawa H, Hirata Y, Kakoki M, et al. Role of nitric oxide-cGMP pathway in adrenomedullin-induced vasodilation in the rat. Hypertension. 1999;33: 689-693.
19. Nuki C, Kawasaki H, Kitamura K, et al. Vasodilator effect of adrenomedullin and calcitonin gene-related peptide receptors in rat mesenteric vascular beds. Biochem Biophys Res Commun. 1993;196:245-251.
20. Nagaya N, Nishikimi T, Uematsu M, et al. Plasma adrenomedullin as an indicator of prognosis after acute myocardial infarction. Heart. 1999;81:483-487.
21. Miyao Y, Nishikimi T, Goto Y, et al. Increased plasma adrenomedullin levels in patients with acute myocardial infarction in proportion to the clinical severity. Heart. 1998;79:39-44.
22. Ehlenz K, Koch B, Preuss P, et al. High levels of circulating adrenomedullin in severe illness: Correlation with C-reactive protein and evidence against the adrenal medulla as site of origin. Exp Clin Endocrinol Diabetes. 1997;105: 156-162.
23. Kikumoto K, Kubo A, Hayashi Y, et al. Increased plasma concentration of adrenomedullin in patients with subarachnoid hemorrhage. Anesth Analg. 1998;87:859-863.
24. Ueda S, Nishio K, Minamino N, et al. Increased plasma levels of adrenomedullin in patients with systemic inflammatory response syndrome. Am J Respir Crit Care Med. 1999;160:132-136.
25. Nishio K, Akai Y, Murao Y, et al. Increased plasma concentrations of adrenomedullin correlate with relaxation of vascular tone in patients with septic shock. Crit Care Med. 1997;25:953-957.
26. Fujioka S. Increased plasma concentration of adrenomedullin during and after major surgery. Surg Today. 2001;31:575-579.
27. Hofbauer KH, Jensen BL, Kurtz A, et al. Tissue hypoxygenation activates the adrenomedullin system in vivo. Am J Physiol Regul Integr Comp Physiol. 2000;278:R513-R519.
28. Nagata D, Hirata Y, Suzuki E, et al. Hypoxia-induced adrenomedullin production in the kidney. Kidney Int. 1999;55:1259-1267.
29. Trollmann R, Schoof E, Beinder E, et al. Adrenomedullin gene expression in human placental tIssue and leukocytes: a potential marker of severe tIssue hypoxia in neonates with birth asphyxia. Eur J Endocrinol. 2002;147:711-716.
30. Cejudo-Martin P, Morales-Ruiz M, Ros J, et al. Hypoxia is an inducer of vasodilator agents in peritoneal macrophages of cirrhotic patients. Hepatology. 2002;36:1172-1179.
31. Vollmar B, Glasz J, Leiderer R, et al. Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion. Am J Pathol. 1994;145:1421-1431.
32. Shimosawa T, Fujita T. Adrenomedullin and its related peptide. Endocr J. 2005;52:1-10.
33. Zhou M, Ba ZF, Chaudry IH, et al. Adrenomedullin binding protein-1 modulates vascular responsiveness to adrenomedullin in late sepsis. Am J Physiol Regul Integr Comp Physiol. 2002;283:R553-R560.
34. Naked GM, Florido MP, Ferreira DP, et al. Deficiency of human complement factor I associated with lowered factor H. Clin Immunol. 2000;96:162-167.
35. Friese MA, Hellwage J, Jokiranta TS, et al. FHL-1/reconectin and factor H: two human complement regulators which are encoded by the same gene are differently expressed and regulated. Mol Immunol. 1999;36:809-818.
36. Schwaeble W, Zwirner J, Schulz TF, et al. Human complement factor H: expression of an additional truncated gene product of 43 kDa in human liver. Eur J Immunol. 1987;17:1485-1489.
37. Luo W, Vik DP. Regulation of complement factor H in a human liver cell line by interferon-gamma. Scand J Immunol. 1999;49:487-494.
38. Glantzounis GK, Salacinski HJ, Yang W, et al. The contemporary role of antioxidant therapy in attenuating liver ischemia-reperfusion injury: a review. Liver Transpl. 2005;11:1031-1047.
39. Lentsch AB, Kato A, Yoshidome H, et al. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology. 2000;32:169-173.
40. Nishikimi T, Saito Y, Kitamura K, et al. Increased plasma levels of adrenomedullin in patients with heart failure. J Am Coll Cardiol. 19950;26: 1424-1431.
41. Rademaker MT, Charles CJ, Lewis LK, et al. Beneficial hemodynamic and renal effects of adrenomedullin in an ovine model of heart failure. Circulation. 1997;96:1983-1990.
42. Nakayama M, Takahashi K, Murakami O, et al. Adrenomedullin in mono-cytes and macrophages: possible involvement of macrophage-derived ad-renomedullin in atherogenesis. Clin Sci (Colch). 1999;97:247-251.
43. Chini EN, Chini CCS, Bolliger C, et al. Cytoprotective effects of adrenomedullin in glomerular cell injury: Central role of cAMP signaling pathway. Kidney Int. 1997;52:917-925.
44. Yoshibayashi M, Kamiya T, Nishikimi T, et al. Elevated plasma levels of adrenomedullin in congenital cyanotic heart disease. Clin Sci (Colch). 1999; 96:543-547.
45. Wu R, Zhou M, Wang P. Adrenomedullin and adrenomedullin binding protein-1 downregulate TNF-alpha in macrophage cell line and rat Kupffer cells. Regul Pept. 2003;112:19-26.
46. Yang S, Zhou M, Fowler DE, et al. Mechanisms of the beneficial effect of adrenomedullin and adrenomedullin-binding protein-1 in sepsis: down-regulation of proinflammatory cytokines. Crit Care Med. 2002;30:2729-2735.
47. Kubo A, Minamino N, Isumi Y, et al. Production of adrenomedullin in macrophage cell line and peritoneal macrophage. J Biol Chem. 1998;273: 16730-16738.
48. Iwamoto M, Osajima A, Tamura M, et al. Adrenomedullin inhibits pressureinduced mesangial MCP-1 expression through activation of protein kinase A. J Nephrol. 2003;16:673-681.
49. Gonzalez-Rey E, Chorny A, Varela N, et al. Urocortin and adrenomedullin prevent lethal endotoxemia by down-regulating the inflammatory response. Am J Pathol. 2006;168:1921-1930.
50. Saito Y, Nakagawa C, Uchida H, et al. Adrenomedullin suppresses fMLP-induced upregulation of CD11b of human neutrophils. Inflammation. 2001; 25:197-201.
51. Ishiyama Y, Kitamura K, Ichiki Y, et al. Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats. Eur J Pharmacol. 1993;241:271-273.
52. Ishiyama Y, Kitamura K, Ichiki Y, et al. Haemodynamic responses to rat adrenomedullin in anaesthetized spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 1995;22:614-618.
53. Cui X, Wu R, Zhou M, et al. Adrenomedullin and its binding protein attenuate the proinflammatory response after hemorrhage. Crit Care Med. 2005;33: 391-398.
54. Wu R, Dong W, Zhou M, et al. A novel approach to maintaining cardiovascular stability after hemorrhagic shock: Beneficial effects of adrenomedullin and its binding protein. Surgery. 2005;137:200-208.
55. Beltowski J, Jamroz A. Adrenomedullin- what we know 10 years since its discovery? Pol J Pharmacol. 2004;56:5-27.